id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1978-N-0018-15901,FDA,FDA-1978-N-0018,PASS Coalition Letter to FDA re CDER Meeting on Sunscreen Ingredients,Other,Letter(s),2025-03-20T04:00:00Z,2025,3,2025-03-20T04:00:00Z,,2025-03-20T20:57:55Z,,0,0,09000064868eb5e8
FDA-1978-N-0018-15902,FDA,FDA-1978-N-0018,EWG - FDA sunscreen meeting,Other,Letter(s),2025-03-20T04:00:00Z,2025,3,2025-03-20T04:00:00Z,,2025-03-20T21:00:04Z,,0,0,09000064868eb5ea
FDA-1978-N-0018-15900,FDA,FDA-1978-N-0018,Covington Withdrawal from OTC Sunscreen IWG,Other,Letter(s),2025-03-07T05:00:00Z,2025,3,2025-03-07T05:00:00Z,,2025-03-07T14:10:04Z,,0,0,09000064868eb2fb
FDA-1978-N-0018-15898,FDA,FDA-1978-N-0018,Sunscreen Work Plan_Advice Letter for CHPA,Other,Letter(s),2025-03-06T05:00:00Z,2025,3,2025-03-06T05:00:00Z,,2025-03-06T15:26:40Z,,0,0,09000064868e6f87
FDA-1978-N-0018-15899,FDA,FDA-1978-N-0018,CHPA sunscreen consortium letter to FDA,Other,Letter(s),2025-03-06T05:00:00Z,2025,3,2025-03-06T05:00:00Z,,2025-03-06T15:26:44Z,,0,0,09000064868e6f89
FDA-1978-N-0018-15897,FDA,FDA-1978-N-0018,EWG_Listening Session_Meeting Minutes,Other,Minutes,2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-01-23T17:46:39Z,,0,0,09000064868d037f
FDA-1978-N-0018-15890,FDA,FDA-1978-N-0018,Clinical and Nonclinical Safety Work Plan for Active Ingredients in OTC Sunscreen Drug Products_Integral Consulting,Other,Letter(s),2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-04-16T14:49:34Z,,0,0,09000064868cfb3a
FDA-1978-N-0018-15891,FDA,FDA-1978-N-0018,Integral Consulting Withdrawal from OTC Sunscreen IWG - Letter to FDA,Other,Letter(s),2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-01-17T21:39:29Z,,0,0,09000064868cfb3c
FDA-1978-N-0018-15893,FDA,FDA-1978-N-0018,Sunscreen Work Plan_FDA Second Advice Letter to Covington & Burling LLP,Other,Letter(s),2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-01-17T21:39:36Z,,0,0,09000064868cfb40
FDA-1978-N-0018-15896,FDA,FDA-1978-N-0018,EWG Listening Session Request,Other,Meeting,2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-01-23T17:44:00Z,,0,0,09000064868d037d
FDA-1978-N-0018-15894,FDA,FDA-1978-N-0018,PASS Listening Session Request,Other,Letter(s),2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-01-23T17:39:32Z,,0,0,09000064868d0379
FDA-1978-N-0018-15895,FDA,FDA-1978-N-0018,AADA Listening Session Request,Other,Meeting,2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-01-23T17:42:09Z,,0,0,09000064868d037b
FDA-1978-N-0018-15892,FDA,FDA-1978-N-0018,Sunscreen Work Plan_FDA Advice Letter to Covington & Burling LLP,Other,Letter(s),2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-01-17T21:39:33Z,,0,0,09000064868cfb3e
FDA-1978-N-0018-15889,FDA,FDA-1978-N-0018,AADA Listening Session Request _01252024,Other,Meeting,2024-07-30T04:00:00Z,2024,7,2024-07-30T04:00:00Z,,2024-07-30T17:57:10Z,,0,0,090000648660e47c
FDA-1978-N-0018-15888,FDA,FDA-1978-N-0018,PASS Listening Session Request_10192023,Other,Meeting,2024-07-30T04:00:00Z,2024,7,2024-07-30T04:00:00Z,,2024-07-30T17:57:05Z,,0,0,090000648660e477
FDA-1978-N-0018-15883,FDA,FDA-1978-N-0018,MGF 400000_Meeting Granted and General Advice Letter for PCPC_FINAL_030322,Other,Letter(s),2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:54:06Z,,0,0,09000064864ef3a4
FDA-1978-N-0018-15870,FDA,FDA-1978-N-0018,MGF 400062_Meeting Granted_02102023SW,Other,Letter(s),2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:51:23Z,,0,0,09000064864ef38b
FDA-1978-N-0018-15867,FDA,FDA-1978-N-0018,MGF 400074 2023.08.18 Meeting Minutes_final,Other,Minutes,2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:50:47Z,,0,0,09000064864ef365
FDA-1978-N-0018-15872,FDA,FDA-1978-N-0018,MGF 400062_Type Z Meeting Request_PCPC_Preliminary Comments,Other,Letter(s),2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:51:52Z,,0,0,09000064864ef38f
FDA-1978-N-0018-15879,FDA,FDA-1978-N-0018,MGF 400005 EMD-Avon_OTC Monograph Meeting Request Denied_Final,Other,Letter(s),2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:53:14Z,,0,0,09000064865c337a
FDA-1978-N-0018-15859,FDA,FDA-1978-N-0018,AADA Sunscreen Listening Session_Meeting Minutes_Final,Other,Minutes,2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:49:05Z,,0,0,09000064865c3279
FDA-1978-N-0018-15884,FDA,FDA-1978-N-0018,MGF 400000_PCPC-Supportive info (10.7.2022),Other,Background Material,2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:54:18Z,,0,0,09000064864ef3a6
FDA-1978-N-0018-15862,FDA,FDA-1978-N-0018,MGF 400074_PCPC-FDA Meeting Request,Other,Meeting,2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:49:37Z,,0,0,09000064864ef33a
FDA-1978-N-0018-15865,FDA,FDA-1978-N-0018,MGF 400074_Type Z Meeting Request_PCPC_Preliminary Responses,Other,Letter(s),2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:50:04Z,,0,0,09000064864ef361
FDA-1978-N-0018-15882,FDA,FDA-1978-N-0018,MGF 400000_PCPC Sunscreen Consortium FDA Meeting Request 3.17.2021,Other,Meeting,2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:53:41Z,,0,0,09000064864ef3a2
FDA-1978-N-0018-15887,FDA,FDA-1978-N-0018,MGF 400000_PCPC_Meeting Request Cancelled_11092022,Other,Letter(s),2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:54:59Z,,0,0,09000064864ef3b0
FDA-1978-N-0018-15881,FDA,FDA-1978-N-0018,PASS Coalition_Listening Session_042021_Meeting Minutes_Final,Other,Minutes,2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:53:33Z,,0,0,09000064864ef39d
FDA-1978-N-0018-15886,FDA,FDA-1978-N-0018,MGF 400000_Personal Care Products Council Unacceptable Letter_11082022,Other,Letter(s),2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:54:41Z,,0,0,09000064864ef3ae
FDA-1978-N-0018-15858,FDA,FDA-1978-N-0018,AADA Sunscreen Listening Session Agenda and Slides 4.18.24,Other,Background Material,2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:48:55Z,,0,0,09000064865c3275
FDA-1978-N-0018-15861,FDA,FDA-1978-N-0018,PASS Follow-up Letter to the FDA Listening Session,Other,Letter(s),2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:49:28Z,,0,0,09000064865c3342
FDA-1978-N-0018-15863,FDA,FDA-1978-N-0018,MGF 400074_Type Z Meeting_PCPC_Meeting Granted_Final,Other,Letter(s),2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:49:46Z,,0,0,09000064864ef33c
FDA-1978-N-0018-15869,FDA,FDA-1978-N-0018,MGF 400062_PCPC-FDA Meeting Request,Other,Meeting,2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:51:14Z,,0,0,09000064864ef389
FDA-1978-N-0018-15885,FDA,FDA-1978-N-0018,MGF 400000_PCPC_OTC IWG Contact Change (10.26.22),Other,Letter(s),2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:54:29Z,,0,0,09000064864ef3a8
FDA-1978-N-0018-15878,FDA,FDA-1978-N-0018,MGF 400005 EMD-Avon_OTC Monograph Meeting Request Acknowledgement,Other,Letter(s),2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:53:06Z,,0,0,09000064865c3376
FDA-1978-N-0018-15880,FDA,FDA-1978-N-0018,EWG_Listening Session_042321_Meeting Minutes_Final,Other,Minutes,2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:53:22Z,,0,0,09000064864ef39b
FDA-1978-N-0018-15866,FDA,FDA-1978-N-0018,MGF 400074_PCPC Response to FDA Preliminary Comments 8.16.2023 FINAL,Other,Letter(s),2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:50:34Z,,0,0,09000064864ef363
FDA-1978-N-0018-15868,FDA,FDA-1978-N-0018,MGF 400074_PCPC Withdrawal from OTC Sunscreen IWG - Letter to FDA - MFG 400074 2.14.2024 FINAL,Other,Letter(s),2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:51:03Z,,0,0,09000064864ef367
FDA-1978-N-0018-15871,FDA,FDA-1978-N-0018,MGF 400062_Meeting Package_Consortium-FDA Meeting,Other,Background Material,2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:51:32Z,,0,0,09000064864ef38d
FDA-1978-N-0018-15873,FDA,FDA-1978-N-0018,MGF 400062_PCPC Revised Agenda and Response to FDA Preliminary Comments 3.21.2023 FINAL COMPOSITE,Other,Meeting,2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:52:21Z,,0,0,09000064864ef391
FDA-1978-N-0018-15874,FDA,FDA-1978-N-0018,MGF 400062_Type Z Meeting Request_PCPC_Meeting Minutes - Final,Other,Minutes,2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:52:29Z,,0,0,09000064864ef395
FDA-1978-N-0018-15864,FDA,FDA-1978-N-0018,MGF 400074_Meeting Package,Other,Background Material,2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:49:55Z,,0,0,09000064864ef33e
FDA-1978-N-0018-15877,FDA,FDA-1978-N-0018,MGF 400005 FDA OTC Meeting Request Submitted,Other,Meeting,2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:52:59Z,,0,0,09000064865c3373
FDA-1978-N-0018-15875,FDA,FDA-1978-N-0018,MGF 400060_PCPC-FDA Meeting Request,Other,Meeting,2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:52:38Z,,0,0,09000064864ef397
FDA-1978-N-0018-15860,FDA,FDA-1978-N-0018,PASS Coalition_Listening Session_12012023_Meeting Minutes_Final,Other,Minutes,2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:49:16Z,,0,0,09000064864ef2ff
FDA-1978-N-0018-15876,FDA,FDA-1978-N-0018,MGF 400060_Personal Care Products Council Unacceptable Letter_12142022,Other,Letter(s),2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T18:52:47Z,,0,0,09000064864ef399
FDA-1978-N-0018-15847,FDA,FDA-1978-N-0018,Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-The-Counter Human Use; Over-The-Counter Monograph Proposed Order (OTC 000008) Extension of Comment Period,Notice,Extension of Comment Period,2021-11-22T05:00:00Z,2021,11,2021-11-22T05:00:00Z,2021-12-28T04:59:59Z,2021-12-25T02:00:48Z,2021-25371,0,0,0900006484e711a4
FDA-1978-N-0018-15828,FDA,FDA-1978-N-0018,Grant of extension of comment period,Other,Letter(s),2021-11-12T05:00:00Z,2021,11,2021-11-12T05:00:00Z,,2024-11-07T00:34:16Z,,1,0,0900006484e42d68
FDA-1978-N-0018-15839,FDA,FDA-1978-N-0018,Request for Extension from NIST,Other,Request for Extension,2021-11-12T05:00:00Z,2021,11,2021-11-12T05:00:00Z,,2021-11-12T18:41:48Z,,0,0,0900006484e42ee1
FDA-1978-N-0018-15824,FDA,FDA-1978-N-0018,Request for Extension from Personal Care Products Council and Consumer Healthcare Products Association,Other,Request for Extension,2021-11-02T04:00:00Z,2021,11,2021-11-02T04:00:00Z,,2021-11-02T16:21:55Z,,0,0,0900006484e06a8a
FDA-1978-N-0018-15815,FDA,FDA-1978-N-0018,"Amending Over-the-Counter Monograph M020: Sunscreen Drug
Products for Over-the-Counter Human Use; Over the Counter Monograph Proposed Order; Availability",Notice,Notice of Availability,2021-09-27T04:00:00Z,2021,9,2021-09-27T04:00:00Z,2021-11-13T04:59:59Z,2021-11-13T02:00:27Z,2021-20780,0,0,0900006484dab14f
FDA-1978-N-0018-15814,FDA,FDA-1978-N-0018,Proposed Administrative Order OTC000008_Amending M020_Sunscreen_Signed24Sept2021,Other,Order,2021-09-24T04:00:00Z,2021,9,2021-09-24T04:00:00Z,2021-11-13T04:59:59Z,2024-11-07T00:31:55Z,,1,0,0900006484da60c4
FDA-1978-N-0018-15812,FDA,FDA-1978-N-0018,EMD Performance Materials Meeting Denied Letter,Other,Letter(s),2021-04-22T04:00:00Z,2021,4,2021-04-22T04:00:00Z,,2021-04-22T13:00:19Z,,0,0,0900006484ab1dd8
FDA-1978-N-0018-15811,FDA,FDA-1978-N-0018,Meeting Minutes for Meeting between EWG and FDA,Other,Letter(s),2020-01-15T05:00:00Z,2020,1,2020-01-15T05:00:00Z,,2020-01-15T21:51:23Z,,0,0,09000064842ac723
FDA-1978-N-0018-15810,FDA,FDA-1978-N-0018,Meeting Request from Environmental Working Group,Other,Letter(s),2020-01-15T05:00:00Z,2020,1,2020-01-15T05:00:00Z,,2020-01-15T21:46:38Z,,0,0,09000064842ac71d
FDA-1978-N-0018-15808,FDA,FDA-1978-N-0018,PASS Coalition and FDA Meeting Minutes_November 1 2016,Other,Minutes,2020-01-15T05:00:00Z,2020,1,2020-01-15T05:00:00Z,,2020-01-15T21:29:32Z,,0,0,09000064842ac513
FDA-1978-N-0018-15809,FDA,FDA-1978-N-0018,Letter from FDA CDER for Announcement of Meeting with PASS Coalition,Other,Letter(s),2020-01-15T05:00:00Z,2020,1,2020-01-15T05:00:00Z,,2020-01-15T21:43:07Z,,0,0,09000064842ac519
FDA-1978-N-0018-15807,FDA,FDA-1978-N-0018,PCPC Meeting - Second Announcement of Meeting Postponement,Other,Briefing Schedule,2019-11-15T05:00:00Z,2019,11,2019-11-15T05:00:00Z,,2019-11-15T18:49:06Z,,0,0,09000064841640a8
FDA-1978-N-0018-15806,FDA,FDA-1978-N-0018,PCPC Meeting -Announcement of Meeting Postponement,Other,Briefing Schedule,2019-11-13T05:00:00Z,2019,11,2019-11-13T05:00:00Z,,2019-11-15T18:48:48Z,,0,0,090000648414f983
FDA-1978-N-0018-15805,FDA,FDA-1978-N-0018,Preliminary Comments from FDA to PCPC Public Meeting Sunscreen Ingredient Deferral Work Plan,Other,Briefing Schedule,2019-11-12T05:00:00Z,2019,11,2019-11-12T05:00:00Z,,2019-11-12T15:30:09Z,,0,0,0900006484145bca
FDA-1978-N-0018-15804,FDA,FDA-1978-N-0018,Briefing Documents for PCPC Meeting Request,Other,Briefing Schedule,2019-11-08T05:00:00Z,2019,11,2019-11-08T05:00:00Z,,2019-12-11T17:20:40Z,,0,0,09000064841307a4
FDA-1978-N-0018-15803,FDA,FDA-1978-N-0018,Request for Meeting from EMD Performance Materials to FDA CDER,Other,Request,2019-10-29T04:00:00Z,2019,10,2019-10-29T04:00:00Z,,2019-10-29T16:02:52Z,,0,0,09000064841057cb
FDA-1978-N-0018-15802,FDA,FDA-1978-N-0018,Response Letter from FDA CDER to Personal Care Product Council,Other,Letter(s),2019-10-29T04:00:00Z,2019,10,2019-10-29T04:00:00Z,,2019-10-29T12:23:13Z,,0,0,0900006484101886
FDA-1978-N-0018-15800,FDA,FDA-1978-N-0018,Meeting Request from Personal Care Products Council,Other,Request,2019-09-17T04:00:00Z,2019,9,,,2019-09-17T19:25:29Z,,0,0,0900006483f8fa27
FDA-1978-N-0018-15798,FDA,FDA-1978-N-0018,PCRM Meeting Request,Other,Request,2019-08-28T04:00:00Z,2019,8,2019-08-28T04:00:00Z,,2019-08-28T18:12:09Z,,0,0,0900006483ed5158
FDA-1978-N-0018-15799,FDA,FDA-1978-N-0018,Physician Committee for Responsible Medicine Meeting Request Denied,Other,Denial,2019-08-28T04:00:00Z,2019,8,2019-08-28T04:00:00Z,,2019-08-28T18:15:14Z,,0,0,0900006483ed4f17
FDA-1978-N-0018-15797,FDA,FDA-1978-N-0018,Response Letter from FDA/CDER to Cosmetic Toiletry and Fragrance Association of South Africa and Dershana Valla,Other,Response(s),2019-08-27T04:00:00Z,2019,8,2019-08-27T04:00:00Z,,2019-08-27T14:23:26Z,,0,0,0900006483ecd1b7
FDA-1978-N-0018-15795,FDA,FDA-1978-N-0018,Extension Request for Extension from Personal Care Products Council (PCPC) and Consumer Healthcare Products Association (CHPA),Other,Request for Extension,2019-08-26T04:00:00Z,2019,8,2019-08-26T04:00:00Z,,2019-08-26T18:47:06Z,,0,0,0900006483ec23d0
FDA-1978-N-0018-15796,FDA,FDA-1978-N-0018,Extension from FDA/CDER to PCPC and CHPA,Other,Letter(s),2019-08-26T04:00:00Z,2019,8,2019-08-26T04:00:00Z,,2019-08-26T18:52:57Z,,0,0,0900006483ec23fd
FDA-1978-N-0018-15793,FDA,FDA-1978-N-0018,FDA Response Letter to CHPA and PCPC Request for Deferral of Eight Sunscreen Ingredients,Other,Response(s),2019-07-29T04:00:00Z,2019,7,2019-07-29T04:00:00Z,,2019-07-29T15:56:16Z,,0,0,0900006483dc652c
FDA-1978-N-0018-2417,FDA,FDA-1978-N-0018,Meeting Minutes with PASS Coalition,Other,Minutes,2019-06-28T04:00:00Z,2019,6,2019-06-28T04:00:00Z,,2019-06-28T14:15:59Z,,0,0,0900006483d4b9ff
FDA-1978-N-0018-2416,FDA,FDA-1978-N-0018,Agency Response Letter from FDA CDER to John G. Moore,Other,Letter(s),2019-06-27T04:00:00Z,2019,6,2019-06-27T04:00:00Z,,2019-06-27T21:11:09Z,,0,0,0900006483d496f0
FDA-1978-N-0018-2133,FDA,FDA-1978-N-0018,Meeting Minutes with Personal Care Product Council,Other,Minutes,2019-06-21T04:00:00Z,2019,6,2019-06-21T04:00:00Z,,2019-06-21T16:24:51Z,,0,0,0900006483d32193
FDA-1978-N-0018-2134,FDA,FDA-1978-N-0018,Meeting Minutes with PASS Coalition,Other,,2019-06-21T00:00:00Z,2019,6,,,2019-06-28T11:34:44Z,,0,1,0900006483d32194
FDA-1978-N-0018-2060,FDA,FDA-1978-N-0018,Minutes of Meeting with American Academy of Dermatology Association,Other,Minutes,2019-05-23T04:00:00Z,2019,5,2019-05-23T04:00:00Z,,2019-05-23T19:24:12Z,,0,0,0900006483cc2376
FDA-1978-N-0018-1649,FDA,FDA-1978-N-0018,Sunscreen Drug Products for Over-the-Counter Human Use; Correction,Proposed Rule,Correction,2019-04-18T04:00:00Z,2019,4,2019-04-18T04:00:00Z,2019-06-28T03:59:59Z,2024-04-16T20:27:21Z,2019-07712,0,0,0900006483bb94cb
FDA-1978-N-0018-1648,FDA,FDA-1978-N-0018,"Sunscreen Drug Products for Over-the-Counter Human Use; Extension of
Comment Period",Proposed Rule,Extension of Comment Period,2019-04-18T04:00:00Z,2019,4,2019-04-18T04:00:00Z,2019-06-28T03:59:59Z,2019-09-24T01:03:41Z,2019-07710,0,0,0900006483bb93d6
FDA-1978-N-0018-1066,FDA,FDA-1978-N-0018,Request for Extension from Personal Care Products Council and Consumer Healthcare Products Association,Other,Request for Extension,2019-03-05T05:00:00Z,2019,3,2019-03-05T05:00:00Z,,2019-03-05T15:03:57Z,,0,0,0900006483abcb19
FDA-1978-N-0018-1065,FDA,FDA-1978-N-0018,Reference 63 - FDA Preliminary Regulatory Impact Analysis,Supporting & Related Material,Background Material,2019-03-01T05:00:00Z,2019,3,,,2019-03-01T17:49:33Z,,0,0,0900006483ab64ac
FDA-1978-N-0018-1055,FDA,FDA-1978-N-0018,Reference 44 - Hong_2014_Effect of zinc oxide nanoparticles on dams and embryo–fetal development in rats,Supporting & Related Material,Background Material,2019-03-01T05:00:00Z,2019,3,,,2019-03-01T13:43:06Z,,0,0,09000064839b2eff
FDA-1978-N-0018-1049,FDA,FDA-1978-N-0018,"Reference 208 - Kasichayanula_2005_Simultaneous Analysis of Insect Repellent DEET, Sunscreen Oxybenzone and Five Relevant Metabolites",Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:47:51Z,,0,0,09000064839b30e1
FDA-1978-N-0018-1034,FDA,FDA-1978-N-0018,Reference 193 - Katz_2008_Insect Repellants- Historical Perspectives and New Developments,Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:26:28Z,,0,0,09000064839b30ad
FDA-1978-N-0018-1037,FDA,FDA-1978-N-0018,Reference 196 - FDA_Food Additive Status List,Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:28:57Z,,0,0,09000064839b30b0
FDA-1978-N-0018-1031,FDA,FDA-1978-N-0018,Reference 190 - EPA_Using Insect Repellents Safely and Effectively,Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:23:32Z,,0,0,09000064839b30aa
FDA-1978-N-0018-1051,FDA,FDA-1978-N-0018,Reference 210 - Yiin_2015_Assessment of Dermal Absorption of DEET-Containing Insect Repellent and Oxybenzone-Containing Sunscreen,Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:51:08Z,,0,0,09000064839b30e3
FDA-1978-N-0018-1032,FDA,FDA-1978-N-0018,Reference 191 - AAP_Choosing an Insect Repellent for Your Child - Tips for Using Repellents Safely,Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:24:41Z,,0,0,09000064839b30ab
FDA-1978-N-0018-1038,FDA,FDA-1978-N-0018,Reference 197 - EPA_RED Facts_Oil of Citronella,Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:29:45Z,,0,0,09000064839b30b1
FDA-1978-N-0018-1035,FDA,FDA-1978-N-0018,Reference 194 - EPA_Technical document IR3535,Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:27:15Z,,0,0,09000064839b30ae
FDA-1978-N-0018-1045,FDA,FDA-1978-N-0018,Reference 204 - Girschik_2008_Deaths from non-melanoma skin cancer in western Australia,Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:39:48Z,,0,0,09000064839b30dd
FDA-1978-N-0018-1048,FDA,FDA-1978-N-0018,Reference 207 - Wang_2007_In vitro percutaneous permeation of the repellant DEET and the sunscreen oxybenzone across human skin,Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:47:01Z,,0,0,09000064839b30e0
FDA-1978-N-0018-1052,FDA,FDA-1978-N-0018,Reference 211 - Montemarano_1997_Insect repellents and the efficacy of sunscreens,Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:52:17Z,,0,0,09000064839b30e4
FDA-1978-N-0018-1047,FDA,FDA-1978-N-0018,Reference 206 - Gu_2005_In Vitro Evaluation of Concurrent Use of Commercially Available Insect Repellent and Sunscreen Preparations,Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:43:25Z,,0,0,09000064839b30df
FDA-1978-N-0018-1030,FDA,FDA-1978-N-0018,Reference 189 - EPA_Active ingredients eligible for minimum risk pesticide products,Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:22:49Z,,0,0,09000064839b3020
FDA-1978-N-0018-1050,FDA,FDA-1978-N-0018,Reference 209 - Kasichayanula_2007_Percutaneous Characterization of the Insect Repellent DEET and the Sunscreen Oxybenzone,Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:48:42Z,,0,0,09000064839b30e2
FDA-1978-N-0018-1041,FDA,FDA-1978-N-0018,"Reference 200 - CDC_Protection against Mosquitoes, Ticks, & Other Arthropods",Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:33:00Z,,0,0,09000064839b32d7
FDA-1978-N-0018-1053,FDA,FDA-1978-N-0018,Letter from FDA CDER to L'Oreal USA Product,Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T17:58:01Z,,0,0,0900006483ab204f
FDA-1978-N-0018-1042,FDA,FDA-1978-N-0018,Reference 201 - AAP_Choosing an Insect Repellent for Your Child - Tips for Using Repellents Safely,Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:37:43Z,,0,0,09000064839b32d8
FDA-1978-N-0018-1039,FDA,FDA-1978-N-0018,Reference 198 - NPIC_Oil of Citronella Fact Sheet,Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:31:14Z,,0,0,09000064839b30b2
FDA-1978-N-0018-1046,FDA,FDA-1978-N-0018,Reference 205 - Ross_2004_Insect repellant interactions- sunscreens enhance DEET absorption,Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:40:48Z,,0,0,09000064839b30de
FDA-1978-N-0018-1044,FDA,FDA-1978-N-0018,Reference 203 - Kaldor_1993_Non-melanoma skin cancer- 10 years of cancer registry based surveillance,Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T15:39:03Z,,0,0,09000064839b32da
FDA-1978-N-0018-1054,FDA,FDA-1978-N-0018,"Letter from FDA CDER to Bare Escentuals Beauty, Inc.",Supporting & Related Material,Background Material,2019-02-28T05:00:00Z,2019,2,,,2019-02-28T17:59:20Z,,0,0,0900006483ab2050